查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1861326

葡甲胺：全球市場佔有率和排名、總收入和需求預測（2025-2031 年）

Meglumine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 83 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球葡甲胺市場規模估計為 1,020 萬美元，預計到 2031 年將達到 1,419 萬美元，2025 年至 2031 年的複合年成長率為 4.1%。

本報告對近期關稅調整和國際戰略反制措施進行了全面評估，涉及葡甲胺的跨境產業佈局、資本配置模式、區域經濟相互依存關係以及供應鏈重組。

葡甲胺是一種白色結晶質粉末，熔點為128-129度C。它易溶於水，微溶於乙醇，幾乎不溶於氯仿。它的味道有甜、鹹、澀味。其分子式為C7H17NO5，分子量為195.21400。密度為1.375，熔點為128-132度C，沸點為490.4度C（760mmHg）。葡甲胺是一種由葡萄糖衍生的氨基糖。

2024年，全球葡甲胺產量達到約352萬噸，全球平均市場價格約每公斤29美元。

葡甲胺市場是製藥和醫療化學行業的一個細分市場，其主要驅動力在於其在注射劑、造影劑和其他治療溶液製劑中作為賦形劑和穩定劑的作用。葡甲胺的需求與製藥行業的成長、診斷影像檢查的發展以及更廣泛的醫療保健基礎設施建設密切相關。全球醫療費用支出不斷成長、慢性病患病率上升以及新興市場診斷服務覆蓋範圍的擴大，都促進了葡甲胺市場的穩定成長。此外，監管機構對高純度藥物成分的重視，也凸顯了可靠供應和品質標準在該市場的重要性。

從競爭格局來看，該市場相對集中，生產主要集中在少數幾家特種化學品製造商手中。價格受原料成本和醫藥級化合物嚴格的合規要求影響。亞太地區存在成長機遇，該地區不斷擴大的製藥產能和醫療影像造影造影需求的成長正在推動消費。然而，市場擴張也面臨許多挑戰，包括替代輔料的出現、供應鏈波動以及製造商進入美國和歐洲等監管嚴格市場所面臨的合規障礙。

本報告旨在對全球葡甲胺市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名，並按地區/國家、類型和應用分析葡甲胺市場。

本報告以銷售量（噸）和收入（百萬美元）為單位，對葡甲胺市場規模、估算和預測進行了呈現，以2024年為基準年，並涵蓋了2020年至2031年的歷史數據和預測數據。報告採用定量和定性分析相結合的方法，幫助讀者制定葡甲胺業務/成長策略，評估市場競爭，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • Merck
  • Tianma
  • Libang Healthcare Group
  • New Hualian Pharm

按類型分類的細分市場

  • 二碘泛酸葡甲胺
  • 羅他拉酸葡甲胺
  • 洛地帕胺葡甲胺

應用領域

  • 助溶劑
  • 造影
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Meglumine was estimated to be worth US$ 10.20 million in 2024 and is forecast to a readjusted size of US$ 14.19 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Meglumine cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Meglumine is a white crystalline powder. Melting point 128-129°C. Soluble in water, slightly soluble in ethanol, almost insoluble in chloroform. Taste sweet and salty astringent. The molecular formula is C7H17NO5 and the molecular weight is 195.21400. The density is 1.375, the melting point is 128-1320C and the boiling point is 490.40C at 760 mmHg. Meglumine is an amino sugar derived from glucose.

In 2024, global Meglumine production reached approximately 352 MT, with an average global market price of around US$ 29 per KG.

The meglumine market is a niche segment within the pharmaceutical and medical chemical industry, primarily driven by its role as an excipient and stabilizing agent in the formulation of injectable drugs, contrast media, and other therapeutic solutions. Its demand is closely tied to the growth of the pharmaceutical sector, diagnostic imaging procedures, and the broader healthcare infrastructure. Increasing global healthcare spending, a rise in chronic disease prevalence, and expanding access to diagnostic services in emerging markets contribute to steady growth for meglumine. Additionally, regulatory emphasis on high-purity pharmaceutical ingredients has enhanced the importance of reliable supply and quality standards in this market.

From a competitive standpoint, the market is relatively consolidated, with production concentrated among a limited number of specialized chemical manufacturers. Pricing dynamics are influenced by raw material costs and the stringent compliance requirements for pharmaceutical-grade compounds. Growth opportunities are seen in Asia-Pacific, where expanding pharmaceutical manufacturing capacity and rising demand for contrast media in medical imaging are boosting consumption. However, market expansion may face challenges from substitution by alternative excipients, fluctuating supply chains, and compliance hurdles for manufacturers seeking entry into regulated markets such as the U.S. and Europe.

This report aims to provide a comprehensive presentation of the global market for Meglumine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Meglumine by region & country, by Type, and by Application.

The Meglumine market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meglumine.

Market Segmentation

By Company

  • Merck
  • Tianma
  • Libang Healthcare Group
  • New Hualian Pharm

Segment by Type

  • Diatrizoate Meglumine
  • Lothalamate Meglumine
  • Lodipamide Meglumine

Segment by Application

  • Cosolvent
  • Contrast agent
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Meglumine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Meglumine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Meglumine in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Meglumine Product Introduction
  • 1.2 Global Meglumine Market Size Forecast
    • 1.2.1 Global Meglumine Sales Value (2020-2031)
    • 1.2.2 Global Meglumine Sales Volume (2020-2031)
    • 1.2.3 Global Meglumine Sales Price (2020-2031)
  • 1.3 Meglumine Market Trends & Drivers
    • 1.3.1 Meglumine Industry Trends
    • 1.3.2 Meglumine Market Drivers & Opportunity
    • 1.3.3 Meglumine Market Challenges
    • 1.3.4 Meglumine Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Meglumine Players Revenue Ranking (2024)
  • 2.2 Global Meglumine Revenue by Company (2020-2025)
  • 2.3 Global Meglumine Players Sales Volume Ranking (2024)
  • 2.4 Global Meglumine Sales Volume by Company Players (2020-2025)
  • 2.5 Global Meglumine Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Meglumine Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Meglumine Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Meglumine
  • 2.9 Meglumine Market Competitive Analysis
    • 2.9.1 Meglumine Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Meglumine Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meglumine as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Diatrizoate Meglumine
    • 3.1.2 Lothalamate Meglumine
    • 3.1.3 Lodipamide Meglumine
  • 3.2 Global Meglumine Sales Value by Type
    • 3.2.1 Global Meglumine Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Meglumine Sales Value, by Type (2020-2031)
    • 3.2.3 Global Meglumine Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Meglumine Sales Volume by Type
    • 3.3.1 Global Meglumine Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Meglumine Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Meglumine Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Meglumine Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Cosolvent
    • 4.1.2 Contrast agent
    • 4.1.3 Other
  • 4.2 Global Meglumine Sales Value by Application
    • 4.2.1 Global Meglumine Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Meglumine Sales Value, by Application (2020-2031)
    • 4.2.3 Global Meglumine Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Meglumine Sales Volume by Application
    • 4.3.1 Global Meglumine Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Meglumine Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Meglumine Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Meglumine Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Meglumine Sales Value by Region
    • 5.1.1 Global Meglumine Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Meglumine Sales Value by Region (2020-2025)
    • 5.1.3 Global Meglumine Sales Value by Region (2026-2031)
    • 5.1.4 Global Meglumine Sales Value by Region (%), (2020-2031)
  • 5.2 Global Meglumine Sales Volume by Region
    • 5.2.1 Global Meglumine Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Meglumine Sales Volume by Region (2020-2025)
    • 5.2.3 Global Meglumine Sales Volume by Region (2026-2031)
    • 5.2.4 Global Meglumine Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Meglumine Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Meglumine Sales Value, 2020-2031
    • 5.4.2 North America Meglumine Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Meglumine Sales Value, 2020-2031
    • 5.5.2 Europe Meglumine Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Meglumine Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Meglumine Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Meglumine Sales Value, 2020-2031
    • 5.7.2 South America Meglumine Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Meglumine Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Meglumine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Meglumine Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Meglumine Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Meglumine Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Meglumine Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Meglumine Sales Value, 2020-2031
    • 6.3.2 United States Meglumine Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Meglumine Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Meglumine Sales Value, 2020-2031
    • 6.4.2 Europe Meglumine Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Meglumine Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Meglumine Sales Value, 2020-2031
    • 6.5.2 China Meglumine Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Meglumine Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Meglumine Sales Value, 2020-2031
    • 6.6.2 Japan Meglumine Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Meglumine Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Meglumine Sales Value, 2020-2031
    • 6.7.2 South Korea Meglumine Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Meglumine Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Meglumine Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Meglumine Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Meglumine Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Meglumine Sales Value, 2020-2031
    • 6.9.2 India Meglumine Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Meglumine Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Merck
    • 7.1.1 Merck Company Information
    • 7.1.2 Merck Introduction and Business Overview
    • 7.1.3 Merck Meglumine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Merck Meglumine Product Offerings
    • 7.1.5 Merck Recent Development
  • 7.2 Tianma
    • 7.2.1 Tianma Company Information
    • 7.2.2 Tianma Introduction and Business Overview
    • 7.2.3 Tianma Meglumine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Tianma Meglumine Product Offerings
    • 7.2.5 Tianma Recent Development
  • 7.3 Libang Healthcare Group
    • 7.3.1 Libang Healthcare Group Company Information
    • 7.3.2 Libang Healthcare Group Introduction and Business Overview
    • 7.3.3 Libang Healthcare Group Meglumine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Libang Healthcare Group Meglumine Product Offerings
    • 7.3.5 Libang Healthcare Group Recent Development
  • 7.4 New Hualian Pharm
    • 7.4.1 New Hualian Pharm Company Information
    • 7.4.2 New Hualian Pharm Introduction and Business Overview
    • 7.4.3 New Hualian Pharm Meglumine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 New Hualian Pharm Meglumine Product Offerings
    • 7.4.5 New Hualian Pharm Recent Development

8 Industry Chain Analysis

  • 8.1 Meglumine Industrial Chain
  • 8.2 Meglumine Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Meglumine Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Meglumine Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Meglumine Market Trends
  • Table 2. Meglumine Market Drivers & Opportunity
  • Table 3. Meglumine Market Challenges
  • Table 4. Meglumine Market Restraints
  • Table 5. Global Meglumine Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Meglumine Revenue Market Share by Company (2020-2025)
  • Table 7. Global Meglumine Sales Volume by Company (2020-2025) & (MT)
  • Table 8. Global Meglumine Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Meglumine Price by Company (2020-2025) & (USD/Kg)
  • Table 10. Key Manufacturers Meglumine Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Meglumine Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Meglumine
  • Table 13. Global Meglumine Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meglumine as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Meglumine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Meglumine Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Meglumine Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Meglumine Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Meglumine Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Meglumine Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)
  • Table 22. Global Meglumine Sales Volume by Type (2020-2025) & (MT)
  • Table 23. Global Meglumine Sales Volume by Type (2026-2031) & (MT)
  • Table 24. Global Meglumine Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Meglumine Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Meglumine Price by Type (2020-2025) & (USD/Kg)
  • Table 27. Global Meglumine Price by Type (2026-2031) & (USD/Kg)
  • Table 28. Global Meglumine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Meglumine Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Meglumine Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Meglumine Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Meglumine Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Meglumine Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)
  • Table 34. Global Meglumine Sales Volume by Application (2020-2025) & (MT)
  • Table 35. Global Meglumine Sales Volume by Application (2026-2031) & (MT)
  • Table 36. Global Meglumine Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Meglumine Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Meglumine Price by Application (2020-2025) & (USD/Kg)
  • Table 39. Global Meglumine Price by Application (2026-2031) & (USD/Kg)
  • Table 40. Global Meglumine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Meglumine Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Meglumine Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Meglumine Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Meglumine Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Meglumine Sales Volume by Region (MT): 2020 VS 2024 VS 2031
  • Table 46. Global Meglumine Sales Volume by Region (2020-2025) & (MT)
  • Table 47. Global Meglumine Sales Volume by Region (2026-2031) & (MT)
  • Table 48. Global Meglumine Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Meglumine Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Meglumine Average Price by Region (2020-2025) & (USD/Kg)
  • Table 51. Global Meglumine Average Price by Region (2026-2031) & (USD/Kg)
  • Table 52. Key Countries/Regions Meglumine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Meglumine Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Meglumine Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Meglumine Sales Volume, (2020-2025) & (MT)
  • Table 56. Key Countries/Regions Meglumine Sales Volume, (2026-2031) & (MT)
  • Table 57. Merck Company Information
  • Table 58. Merck Introduction and Business Overview
  • Table 59. Merck Meglumine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 60. Merck Meglumine Product Offerings
  • Table 61. Merck Recent Development
  • Table 62. Tianma Company Information
  • Table 63. Tianma Introduction and Business Overview
  • Table 64. Tianma Meglumine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 65. Tianma Meglumine Product Offerings
  • Table 66. Tianma Recent Development
  • Table 67. Libang Healthcare Group Company Information
  • Table 68. Libang Healthcare Group Introduction and Business Overview
  • Table 69. Libang Healthcare Group Meglumine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 70. Libang Healthcare Group Meglumine Product Offerings
  • Table 71. Libang Healthcare Group Recent Development
  • Table 72. New Hualian Pharm Company Information
  • Table 73. New Hualian Pharm Introduction and Business Overview
  • Table 74. New Hualian Pharm Meglumine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 75. New Hualian Pharm Meglumine Product Offerings
  • Table 76. New Hualian Pharm Recent Development
  • Table 77. Key Raw Materials Lists
  • Table 78. Raw Materials Key Suppliers Lists
  • Table 79. Meglumine Downstream Customers
  • Table 80. Meglumine Distributors List
  • Table 81. Research Programs/Design for This Report
  • Table 82. Key Data Information from Secondary Sources
  • Table 83. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Meglumine Product Picture
  • Figure 2. Global Meglumine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Meglumine Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Meglumine Sales Volume (2020-2031) & (MT)
  • Figure 5. Global Meglumine Sales Price (2020-2031) & (USD/Kg)
  • Figure 6. Meglumine Report Years Considered
  • Figure 7. Global Meglumine Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Meglumine Players Sales Volume Ranking (2024) & (MT)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Meglumine Revenue in 2024
  • Figure 10. Meglumine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Diatrizoate Meglumine Picture
  • Figure 12. Lothalamate Meglumine Picture
  • Figure 13. Lodipamide Meglumine Picture
  • Figure 14. Global Meglumine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Meglumine Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Meglumine Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)
  • Figure 17. Global Meglumine Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Meglumine Price by Type (2020-2031) & (USD/Kg)
  • Figure 19. Product Picture of Cosolvent
  • Figure 20. Product Picture of Contrast agent
  • Figure 21. Product Picture of Other
  • Figure 22. Global Meglumine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 23. Global Meglumine Sales Value Market Share by Application, 2024 & 2031
  • Figure 24. Global Meglumine Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)
  • Figure 25. Global Meglumine Sales Volume Market Share by Application, 2024 & 2031
  • Figure 26. Global Meglumine Price by Application (2020-2031) & (USD/Kg)
  • Figure 27. North America Meglumine Sales Value (2020-2031) & (US$ Million)
  • Figure 28. North America Meglumine Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Europe Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Europe Meglumine Sales Value by Country (%), 2024 VS 2031
  • Figure 31. Asia Pacific Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Asia Pacific Meglumine Sales Value by Region (%), 2024 VS 2031
  • Figure 33. South America Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. South America Meglumine Sales Value by Country (%), 2024 VS 2031
  • Figure 35. Middle East & Africa Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. Middle East & Africa Meglumine Sales Value by Country (%), 2024 VS 2031
  • Figure 37. Key Countries/Regions Meglumine Sales Value (%), (2020-2031)
  • Figure 38. Key Countries/Regions Meglumine Sales Volume (%), (2020-2031)
  • Figure 39. United States Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. United States Meglumine Sales Value by Type (%), 2024 VS 2031
  • Figure 41. United States Meglumine Sales Value by Application (%), 2024 VS 2031
  • Figure 42. Europe Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. Europe Meglumine Sales Value by Type (%), 2024 VS 2031
  • Figure 44. Europe Meglumine Sales Value by Application (%), 2024 VS 2031
  • Figure 45. China Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. China Meglumine Sales Value by Type (%), 2024 VS 2031
  • Figure 47. China Meglumine Sales Value by Application (%), 2024 VS 2031
  • Figure 48. Japan Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. Japan Meglumine Sales Value by Type (%), 2024 VS 2031
  • Figure 50. Japan Meglumine Sales Value by Application (%), 2024 VS 2031
  • Figure 51. South Korea Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 52. South Korea Meglumine Sales Value by Type (%), 2024 VS 2031
  • Figure 53. South Korea Meglumine Sales Value by Application (%), 2024 VS 2031
  • Figure 54. Southeast Asia Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 55. Southeast Asia Meglumine Sales Value by Type (%), 2024 VS 2031
  • Figure 56. Southeast Asia Meglumine Sales Value by Application (%), 2024 VS 2031
  • Figure 57. India Meglumine Sales Value, (2020-2031) & (US$ Million)
  • Figure 58. India Meglumine Sales Value by Type (%), 2024 VS 2031
  • Figure 59. India Meglumine Sales Value by Application (%), 2024 VS 2031
  • Figure 60. Meglumine Industrial Chain
  • Figure 61. Meglumine Manufacturing Cost Structure
  • Figure 62. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 63. Bottom-up and Top-down Approaches for This Report
  • Figure 64. Data Triangulation
  • Figure 65. Key Executives Interviewed